The care of the older adult with acute myeloid leukemia or a myelodysplastic syndrome

Larry D. Cripe, Cheryl K. Rutledge

Research output: Contribution to journalReview article

1 Scopus citations


The majority of patients diagnosed with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) are 60 years of age or older. The expected survival and impact of the disease depend on its subtype. The goals of treatment are symptomatic palliation and prolongation of life. Cure is rarely achieved. The options for care range from intensive chemotherapy to transfusions to end-of-life care. Intensive therapy may prolong life modestly. However, the coexistence of co-morbid conditions and a lack of efficacy limit the number of candidates for intensive therapy. Therefore, most older individuals with MDS or AML receive supportive care with transfusions.

Original languageEnglish (US)
Pages (from-to)35-41
Number of pages7
JournalAnnals of Long-Term Care
Issue number10
StatePublished - Oct 1 2002


ASJC Scopus subject areas

  • Gerontology
  • Geriatrics and Gerontology

Cite this